Search Results
Nov 26, 2025, 07:00 ET Blue Sky Uranium Completes Comprehensive GAP Analysis for Ivana Deposit and Identifies Clear Roadmap to Feasibility
updateQ2 2026: Preliminary metallurgical results and commencement of extended metallurgical testsQ3 2026: PFS level of engineeringQ3 2026: Final mineral resource report and PFS completionQ2 2027: Final Metallurgical test report and FS completionQ3 2027: EIA submissionThe
More news about: Blue Sky Uranium Corp.
Nov 25, 2025, 07:30 ET Medicare Finalizes Reimbursement for Caristo's CaRi-Plaque™ Across Hospital and Office Settings
New OPPS and PFS reimbursement rates give hospitals, imaging centers and physicians a unified path to use AI plaque analysis starting 2026STAMFORD, Conn., Nov. 25, 2025 /PRNewswire/ --
More news about: CARISTO DIAGNOSTICS
Nov 24, 2025, 16:30 ET Lilly to highlight progress across key programs in early and advanced hormone receptor-positive breast cancer at the 2025 San Antonio Breast Cancer Symposium
metastatic breast cancer. The presentation will feature a pre-specified interim overall survival (OS) analysis, with updates on progression-free survival (PFS) and time to chemotherapy (TTC). In addition, a poster presentation will provide results of an exploratory analysis of early changes in circulating tumor
More news about: Eli Lilly and Company
Nov 24, 2025, 08:30 ET Amorphical Announces First Patient Enrolled in Phase 2 Clinical Trial of Nano-Amorphous Mineral-Based Therapy in Stage IV Pancreatic Cancer Patients
Center and the Israel Ministry of Health, aims to investigate whether this therapy can extend the survival of these patients by time to progression (PFS), overall survival (OS), response rate (ORR), and change in quality of life using a dedicated questionnaire. Data is expected in Q3 of 2026.Pancreatic
More news about: Amorphical
Nov 24, 2025, 07:30 ET Defense Metals Receives Support from the McLeod Lake Indian Band while Meeting in Ottawa with Canadian Government Officials to Advance the Wicheeda Rare Earth Project
hydroelectric transmission lines, gas pipelines, rail services and the port facilities at Prince Rupert. The Company completed a Preliminary Feasibility Study (PFS) in 2025 (refer to the Company's news releases dated February 18, and April 7, 2025).For further information, please visit
More news about: Defense Metals Corp.
Nov 24, 2025, 07:00 ET Kelun-Biotech Announces Phase III Trial of Sac-TMT in Combination with KEYTRUDA® (pembrolizumab) as First-Line Treatment for PD-L1-Positive NSCLC Met Primary Endpoint
second-line and later settings and has achieved dual benefits in PFS and overall survival (OS) in the EGFR-TKI-resistant lung cancer population, making it the first ADC to show statistically significant and clinically meaningful improvements in both PFS and OS compared to platinum doublet chemotherapy. These
More news about: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Nov 24, 2025, 07:00 ET Data from Genprex's Acclaim-1 Phase 1 Gene Therapy Clinical Trial Published in Clinical Lung Cancer
cycles over approximately 10 months before disease progression occurred.The extended Progression Free Survival (PFS) of each of these patients is consistent with long-term PFS seen in several patients in prior early-stage clinical trials of REQORSA and is not expected with treatment with osimertinib
More news about: Genprex, Inc.
Nov 24, 2025, 07:00 ET BioLineRx Reports Third Quarter 2025 Financial Results and Provides Corporate Update
and standard chemotherapy (gemcitabine and nab-paclitaxel).A prespecified interim analysis is planned when 40% of progression-free survival (PFS) events are observed.Sickle Cell Disease (SCD) & Gene TherapyAnnounced that a poster featuring final
More news about: BioLineRx Ltd.
Nov 20, 2025, 07:58 ET ARIS MINING TO ACQUIRE REMAINING 49% OF SOTO NORTE, SECURING 100% OWNERSHIP AND ADVANCING A CLEAR PATH TO 1 Moz/year
and Marmato in Colombia and the near-term advancement of Toroparu in Guyana, which is expected to be construction-ready following completion of the PFS next year. Full alignment and strategic control: 100% ownership enhances Aris Mining's ability
More news about: Aris Mining Corporation
Nov 19, 2025, 17:00 ET ARIS MINING AND THE GOVERNMENT OF COLOMBIA REACH LONG-TERM AGREEMENT FOCUSED ON SECURITY AND SUSTAINABILITY TO END ICSID ARBITRATION
gold project, where a new Preliminary Economic Assessment has been completed and a Prefeasibility Study is in progress. Following completion of the PFS, Toroparu will be positioned to advance toward construction. Aris Mining also holds a 51% interest in the Soto Norte joint venture,
More news about: Aris Mining Corporation
Nov 19, 2025, 16:01 ET FDA GRANTS FULL APPROVAL TO AMGEN'S IMDELLTRA® IN EXTENSIVE STAGE SMALL CELL LUNG CANCER
Japan).3,4 The primary outcome measure of the trial is OS.3 Key secondary outcome measures include progression-free survival (PFS) and patient-reported outcomes (PROs) including disease-related symptoms, physical function, and quality of life.3 Results from DeLLphi-304
More news about: Amgen
Nov 19, 2025, 08:46 ET CMS Establishes National Pricing for Vesiflo's inFlow™ Voiding Prosthesis
CPT® codes related to physician procedures for the device. This decision, included in the Calendar Year 2026 Medicare Physician Fee Schedule (PFS) Final Rule (CMS-1832-F), will take effect January 1, 2026, ensuring consistent nationwide coverage for physicians treating women with permanent urinary
More news about: Vesiflo
Nov 18, 2025, 12:47 ET AbbVie Announces U.S. FDA Approval of EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide for Relapsed or Refractory Follicular Lymphoma
compared to 74% of patients treated with R2 (n=181/245, 95% CI: 68%-79%). The median for dual primary endpoint of progression-free survival (PFS), was not reached (NR) among patients treated with EPKINLY + R2 (95% CI: 21.9 months - NR) compared to 11.2 months for patients treated with
More news about: AbbVie
Nov 18, 2025, 07:00 ET First Mining Announces Updated Pre-Feasibility Study for the Springpole Gold Project, Ontario, Canada
to announce the positive results of an updated Pre-Feasibility Study ("2025PFS") completed for its 100%-owned Springpole Gold Project (the "Project" or "Springpole") located in Ontario, Canada. The 2025 PFS results support a 30,000 tonnes-per-day ("tpd") open pit mining
More news about: First Mining Gold Corp.
Nov 17, 2025, 22:03 ET Mayfair Gold Q3 2025 Financial and Operating Results
gold project through permitting, detailed engineering and community engagement. The company continued to advance work on the Pre-Feasibility Study ("PFS") for a 4,800 tpd open pit operation targeting the high-grade near surface zone of mineralization at Fenn-Gib. The Company
More news about: Mayfair Gold Corp.
Nov 17, 2025, 06:30 ET Nuvalent Announces Positive Topline Pivotal Data from ALKOVE-1 Clinical Trial of Neladalkib for TKI Pre-treated Patients with Advanced ALK-positive NSCLC
randomized 1:1 to receive neladalkib or ALECENSA® (alectinib). The primary endpoint is progression free survival (PFS) based on Blinded Independent Central Review (BICR). Secondary endpoints include PFS based on investigator's assessment, and BICR assessment of objective response rate (ORR), intracranial objective
More news about: Nuvalent, Inc.
Nov 17, 2025, 06:00 ET Positive HERIZON-GEA-01 Phase 3 Results Support Ziihera® (zanidatamab-hrii) as HER2-Targeted Agent-of-Choice and Ziihera Combination Regimens as New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma
Ziihera plus chemotherapy showed a clinically meaningful and statistically significant improvement in PFS versus trastuzumab and chemotherapy, and a clinically meaningful effect with a strong trend toward statistical significance for OS at the first OS interim
More news about: Jazz Pharmaceuticals plc
Nov 17, 2025, 06:00 ET Thesis Gold Continues to Derisk Lawyers-Ranch Through Drilling
of British Columbia. This year's work focused on geotechnical, hydrological, and metallurgical studies to support the ongoing Prefeasibility Study ("PFS") and to advance the technical work required for future feasibility-level designs, reflecting the Company's continued commitment to de-risking the Project.
More news about: Thesis Gold Inc.
Nov 17, 2025, 04:00 ET Denison Announces Agreements with Skyharbour Resources, Increasing Denison's Strategic Foothold Surrounding Wheeler River
feasibility study was completed for the Phoenix deposit as an ISR mining operation, and an update to the previously prepared 2018 Pre-Feasibility Study ('PFS') was completed for Wheeler River's Gryphon deposit as a conventional underground mining operation. Based on the respective studies, both deposits have
More news about: Denison Mines Corp.
Nov 13, 2025, 14:19 ET AICPA Holiday Spending Survey Reveals Budgeting, Debt and a Bit of Regret
"The 2025 holiday season could see many Americans balancing the desire to celebrate with the reality of financial strain," says Dan Snyder, CPA/PFS, Director of AICPA Personal Financial Planning. "Economic uncertainty may lead Americans to cut back on holiday spending and nearly half of those who
More news about: AICPA
Nov 13, 2025, 08:59 ET Stroudwater Associates Releases the 2025 Rural Provider Compensation Report
the current CMS physician fee schedule for determining wRVUs, and over half the organizations surveyed did not know which CMS physician fee schedule (PFS) they were using.63.6% of the organizations surveyed were using the 2023 CMS physician fee schedule.
More news about: Stroudwater Associates
Nov 12, 2025, 17:08 ET i-80 Gold Reports Third Quarter 2025 Results and Project Development Progress
underground (FS) — Q1 2026 Granite Creek open pit (PFS/FS) — Timeline under review Archimedes underground (FS) — Q1 2027 Mineral Point open pit (PFS/FS) — Timeline under review
More news about: i-80 Gold Corp
Nov 12, 2025, 13:00 ET Year-End Tax and Financial Planning Tips from CPAs
next. "Taking action before the end of this year can be a huge benefit to your financial health in 2026," says Dan Snyder, CPA/PFS, Director of AICPA Personal Financial Planning. "There have been many changes in the tax and financial planning space this year and now is the time
More news about: AICPA
Nov 12, 2025, 08:00 ET Cypherpunk Technologies (formerly Leap Therapeutics) Reports Third Quarter 2025 Financial Results
demonstrated a statistically significant benefit on overall response rate (ORR) and progression-free survival (PFS) in patients with high levels of DKK1, along with a positive trend on ORR and PFS in the full intent-to-treat population. Across the
More news about: Cypherpunk Technologies Inc.
Nov 12, 2025, 08:00 ET Cypherpunk Technologies (formerly Leap Therapeutics) Reports Third Quarter 2025 Financial Results
demonstrated a statistically significant benefit on overall response rate (ORR) and progression-free survival (PFS) in patients with high levels of DKK1, along with a positive trend on ORR and PFS in the full intent-to-treat population. Across the
More news about: Cypherpunk Technologies Inc.